Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
20.09
-0.91 (-4.33%)
Dec 3, 2024, 4:00 PM EST - Market closed

Viridian Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
1,5911,1451,1764296415
Upgrade
Market Cap Growth
159.31%-2.58%173.76%568.00%321.43%-83.67%
Upgrade
Enterprise Value
1,05098989237944-9
Upgrade
Last Close Price
20.0921.7829.2119.7716.457.20
Upgrade
PS Ratio
5752.023647.53663.46144.9461.233.42
Upgrade
PB Ratio
3.072.592.982.290.540.97
Upgrade
P/TBV Ratio
3.354.864.657.97-0.97
Upgrade
EV/Sales Ratio
3477.823150.76503.65127.7941.48-
Upgrade
Debt / Equity Ratio
0.030.050.010.000.000.53
Upgrade
Asset Turnover
0.000.000.010.020.010.09
Upgrade
Quick Ratio
18.2117.9312.7314.4811.962.67
Upgrade
Current Ratio
18.5518.2612.9314.6812.142.92
Upgrade
Return on Equity (ROE)
-51.88%-56.80%-44.57%-51.61%-163.07%-124.81%
Upgrade
Return on Assets (ROA)
-32.14%-34.37%-26.28%-29.75%-31.36%-51.84%
Upgrade
Return on Capital (ROIC)
-34.14%-36.80%-28.52%-32.28%-35.04%-58.31%
Upgrade
Earnings Yield
-16.15%-20.76%-11.05%-18.49%-172.21%-274.49%
Upgrade
FCF Yield
-12.41%-16.16%-8.05%-12.79%-46.39%-236.90%
Upgrade
Buyback Yield / Dilution
-42.07%-39.48%-169.22%-235.07%-70.27%-5.87%
Upgrade
Total Shareholder Return
-42.07%-39.48%-169.22%-235.07%-70.27%-5.87%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.